Role of thymulin or its analogue as a new analgesic molecule

BACH JF, 1983, CLIN IMMUNOL ALLERGY, V3, P133; BACH JF, 1977, NATURE, V266, P55, DOI 10.1038-266055a0; BALASINGAM V, 1994, J NEUROSCI, V14, P846; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016-0167-5699(94)90205-4; BUCKINGHAM JC, 1992, J NEUROENDOCRINOL, V4, P295, DOI 10.1111-j.1365-2826.1992.tb00171.x; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660; Dantzer R, 1998, ANN NY ACAD SCI, V840, P586, DOI 10.1111-j.1749-6632.1998.tb09597.x; Dardenne M, 2000, PAIN AND NEUROIMMUNE INTERACTIONS, P127; DARDENNE M, 1982, P NATL ACAD SCI-BIOL, V79, P5370, DOI 10.1073-pnas.79.17.5370; DASCOMBE MJ, 1979, BRIT J PHARMACOL, V66, P565; DESIMONI MG, 1995, ENDOCRINOLOGY, V136, P897, DOI 10.1210-en.136.3.897; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001-jama.269.14.1829; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038-334698a0; Hori T, 2000, PAIN AND NEUROIMMUNE INTERACTIONS, P171; Kanaan SA, 1996, PAIN, V66, P373, DOI 10.1016-0304-3959(96)03068-0; Kanaan SA, 1998, J NEUROIMMUNOL, V86, P142, DOI 10.1016-S0165-5728(98)00027-7; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016-S0166-2236(00)02088-9; Lemke R, 1999, GLIA, V27, P75, DOI 10.1002-(SICI)1098-1136(199907)27:175::AID-GLIA83.0.CO;2-J; LEWIN GR, 1993, J NEUROSCI, V13, P2136; MAIER SF, 1993, BRAIN RES, V623, P321, DOI 10.1016-0006-8993(93)91446-Y; PLEAU JM, 1979, IMMUNOL LETT, V1, P179, DOI 10.1016-0165-2478(79)90025-7; Poole S, 2000, PAIN AND NEUROIMMUNE INTERACTIONS, P31; POOLE S, 1992, BRIT J PHARMACOL, V106, P489; Saade NE, 1999, J NEUROIMMUNOL, V97, P16, DOI 10.1016-S0165-5728(99)00031-4; Saade NE, 2003, NEUROSCIENCE, V119, P155, DOI 10.1016-S0306-4522(03)00072-1; Saade NE, 1998, J NEUROIMMUNOL, V91, P171, DOI 10.1016-S0165-5728(98)00176-3; Saade NE, 1997, BRAIN RES, V769, P57; SAFIEH B, 1991, J PHYSL, V438, P50; Safieh-Garabedian B, 1998, PAIN MECHANISMS AND MANAGEMENT, P131; SafiehGarabedian B, 1997, BRIT J PHARMACOL, V121, P1619, DOI 10.1038-sj.bjp.0701313; SafiehGarabedian B, 1997, BRAIN BEHAV IMMUN, V11, P185, DOI 10.1006-brbi.1997.0491; SafiehGarabedian B, 1997, J NEUROIMMUNOL, V73, P162, DOI 10.1016-S0165-5728(96)00195-6; Safieh-Garabedian B, 2000, NEUROPHARMACOLOGY, V39, P1653, DOI 10.1016-S0028-3908(99)00247-6; Safieh-Garabedian B, 1999, NEUROIMMUNOMODULAT, V6, P39, DOI 10.1159-000026362; Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210-er.21.4.412; Spranger M, 1996, NEUROSCIENTIST, V2, P293, DOI 10.1177-107385849600200515; Turrin NP, 2001, BRAIN RES BULL, V54, P443, DOI 10.1016-S0361-9230(01)00445-2; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073-pnas.91.6.2046; vonGaudecker B, 1997, MICROSC RES TECHNIQ, V38, P237, DOI 10.1002-(SICI)1097-0029(19970801)38:3237::AID-JEMT53.0.CO;2-J; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016-0306-4522(94)90366-2